Scottsdale Research Institute is a Phoenix-based clinical trials site that is dedicated to advancing the state of medical care through rigorous research. SRI strives to conduct high quality, controlled scientific studies intended to ascertain the general medical safety and efficacy of cannabis and cannabis products and examine various forms of cannabis administration. SRI is currently conducting the only federally-authorized study of medical cannabis for Post-Traumatic Stress Disorder (PTSD) for military veterans in the United States.
The following diseases or conditions are additional areas of interest for future funding and research:
SRI also seeks to highlight and raise awareness of current barriers to cannabis research caused by Drug War-era policies and legislation.
SRI does not encourage or sanction the social or recreational use of cannabis, but supports the expansion of research efforts to determine the applicability of cannabis as medicine for any conditions for which it might prove safe and effective.
The SRI Institute will coordinate and support cannabis research throughout the State of Arizona and beyond. Research will focus on the potential medicinal benefits of cannabis for diseases and conditions as specified by the National Academy of Sciences, Institute of Medicine Report (1999) and by the Workshop on the Medical Utility of Marijuana, National Institutes of Health (1997).